Abstract
Cell-mediated immunity to varicella-zoster antigen was assessed by lymphocyte transformation in fourteen patients with acute herpes zoster and in a group of twelve healthy controls. There was a significant dimunition in cell-mediated immunity to this antigen in the patient group when compared to the controls but no definite difference was observed in the responses to phytohaemagglutinin and PPD measured at the same time. It was suggested that this lack of cell-mediated immunity contributes to the evolution of the disease.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armstrong R. W., Gurwith M. J., Waddell D., Merigan T. C. Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia. N Engl J Med. 1970 Nov 26;283(22):1182–1187. doi: 10.1056/NEJM197011262832202. [DOI] [PubMed] [Google Scholar]
- BENTZON J. W. The effect of certain infectious diseases on tuberculin allergy. Tubercle. 1953 Feb;34(2):34–41. doi: 10.1016/s0041-3879(53)80013-9. [DOI] [PubMed] [Google Scholar]
- Brunell P. A., Ross A., Miller L. H., Kuo B. Prevention of varicella by zoster immune globulin. N Engl J Med. 1969 May 29;280(22):1191–1194. doi: 10.1056/NEJM196905292802201. [DOI] [PubMed] [Google Scholar]
- Burnet F. M. An immunological approach to ageing. Lancet. 1970 Aug 15;2(7668):358–360. doi: 10.1016/s0140-6736(70)92886-2. [DOI] [PubMed] [Google Scholar]
- Chang T. W. Recurrent viral infection (reinfection). N Engl J Med. 1971 Apr 8;284(14):765–773. doi: 10.1056/NEJM197104082841406. [DOI] [PubMed] [Google Scholar]
- Chawla P. L., Stutzman L., Dubois R. E., Kim U., Sokal J. E. Long survival in Hodgkin's disease. Am J Med. 1970 Jan;48(1):85–92. doi: 10.1016/0002-9343(70)90102-6. [DOI] [PubMed] [Google Scholar]
- Fosdick W. M., Parsons J. L., Hill D. F. Long-term cyclophosphamide therapy in rheumatoid arthritis. Arthritis Rheum. 1968 Apr;11(2):151–161. doi: 10.1002/art.1780110205. [DOI] [PubMed] [Google Scholar]
- Goffinet D. R., Glatstein E. J., Merigan T. C. Herpes Zoster-Varicella infections and lymphoma. Ann Intern Med. 1972 Feb;76(2):235–240. doi: 10.7326/0003-4819-76-2-235. [DOI] [PubMed] [Google Scholar]
- Gold E. Characteristics of herpes zoster and varicella viruses propagated in vitro. J Immunol. 1965 Oct;95(4):683–691. [PubMed] [Google Scholar]
- HOPE-SIMPSON R. E. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med. 1965 Jan;58:9–20. [PMC free article] [PubMed] [Google Scholar]
- Merigan T. C., Stevens D. A. Viral infections in man associated with acquired immunological deficiency states. Fed Proc. 1971 Nov-Dec;30(6):1858–1864. [PubMed] [Google Scholar]
- Meurisse E. V. Laboratory studies on the varicella-zoster virus. J Med Microbiol. 1969 Aug;2(3):317–325. doi: 10.1099/00222615-2-3-317. [DOI] [PubMed] [Google Scholar]
- Miller L. H., Brunell P. A. Zoster, reinfection or activation of latent virus? Observations on the antibody response. Am J Med. 1970 Oct;49(4):480–483. doi: 10.1016/s0002-9343(70)80042-0. [DOI] [PubMed] [Google Scholar]
- Rifkind D. The activation of varicella-zoster virus infections by immunosuppressive therapy. J Lab Clin Med. 1966 Sep;68(3):463–474. [PubMed] [Google Scholar]
- Schimpff S., Serpick A., Stoler B., Rumack B., Mellin H., Joseph J. M., Block J. Varicella-Zoster infection in patients with cancer. Ann Intern Med. 1972 Feb;76(2):241–254. doi: 10.7326/0003-4819-76-2-241. [DOI] [PubMed] [Google Scholar]
- Taylor-Robinson D., Slack P. M. Exogenous or endogenous causation of shingles. Lancet. 1972 Jan 15;1(7742):151–151. doi: 10.1016/s0140-6736(72)90721-0. [DOI] [PubMed] [Google Scholar]
- Zweiman B., Pappagianis D., Maibach H., Hildreth E. A. Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int Arch Allergy Appl Immunol. 1971;40(6):834–841. doi: 10.1159/000230466. [DOI] [PubMed] [Google Scholar]